Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Cytokine therapy is promising for treating skin conditions like vitiligo and psoriasis.

CD25+ CD4+ Tregs and certain plasma proteins are linked to hair loss.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Gingerol may help treat chronic graft-versus-host disease by improving immune cell balance.

Inhibiting HSP90 increases cell adaptability and survival under stress.

Leukocyte recruitment is complex but crucial for resolving inflammation and developing effective therapies.

MicroRNAs could lead to new treatments for skin diseases, but more research is needed.

Controlling transposable elements is crucial for successful tissue regeneration.

Neurosteroids help balance brain signals when certain inhibitions are reduced.

miR-486 may help prevent hair loss in alopecia areata.

Innate lymphoid cells help control skin bacteria by regulating sebaceous glands.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Stress and certain chemicals affect hair growth by interacting with the immune and nervous systems.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

3D spheroid culture makes stem cells better at reducing inflammation.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Genes affect cytokine production, which can influence chronic diseases, and certain interventions may help prevent related molecular damage.

Anti-CD19 therapy may help treat SLE and NMOSD.

Some treatments that modify the immune system might help with certain types of hair loss but haven't been explored for common hair loss alone.

Exosomes show promise as effective treatments for autoimmune skin diseases with fewer side effects.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.